Filing Signals

Source: SEC EDGAR Compiled 2026-09-14 08:28 UTC All 21 checks passing

← All events

Vaxart, Inc.

CIK 72444 VXRT·Biological Products · All EDGAR filings ↗

Going concern Filing comparison

Vaxart, Inc. said management's plans alleviate substantial doubt about going concern

Substantial doubt about ability to continue as a going concern Substantial doubt raised, alleviated by management's plans

Any of these actions could harm our business, results of operations and prospects. Based on management’s current plan, we expect to have cash runway into the second quarter of 2027. Accordingly, management concluded that the conditions and events that previously raised substantial doubt about our ability to continue as a going concern have been alleviated. The accompanying consolidated financial statements have been prepared assuming that we will continue as a going concern, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of…
Evidence
Blank check
No
Comparable
Yes
Current state
doubt_alleviated
Current state label
Substantial doubt raised, alleviated by management's plans
Direction
eased
Located in
filing body
Prior filed
2025-03-20
Prior form
10-K
Prior state
substantial_doubt
Prior state label
Substantial doubt about ability to continue as a going concern
Source
ASC 205-40 going-concern note comparison
Why
Disclosure about the company's ability to continue as a going concern changed compared with its previous report.